Vision
D. Anders
HI-TRON Mainz aspires to revolutionize cancer therapy, particularly with personalized approaches turning the patient‘s immune system into a powerful weapon against cancer.
To this end, the founding partners will join forces to build a collaborative translational platform for personalized cancer immunotherapy covering:
• Personalized biomarker research
• Development of new concepts for immunotherapy
• Clinical implementation through clinical translation
